Sponsor:
Johnson & Johnson Enterprise Innovation Inc.
Code:
NCT06116786
Conditions
Carcinoma, Non-small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
JNJ-86974680
Cetrelimab
Radiation Therapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Johnson & Johnson Enterprise Innovation Inc. on 2026-05-08.